作为智能药物输送系统的康胺载聚 (N-异烯胺) 纳米颗粒的控制释放和抗生素效果
Liang Lei1, Shanlong Li2, Xuefeng Kang1
1Department of Orthopaedics, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, China.
Journal of applied biomaterials & functional materials
|March 15, 2025
概括
研究人员开发了新的聚N-异烯胺 (PNIPAAm) 纳米囊,以有效地输送万科米辛 (VA). 这种新的PNIPAAm-VA系统显示无毒性和受控的药物释放,为细菌感染提供了有前途的注射剂.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 范科米辛 (VA) 对于治疗细菌感染至关重要,但在静脉注射时会引起副作用.
- 开发更安全,更有效的VA药物输送系统是必不可少的.
研究的目的:
- 为了合成和表征聚N-异烯胺 (PNIPAAm) 虚空纳米囊用于万科米辛 (VA) 封装.
- 评估新型PNIPAAm-VA纳米载体的体内细胞毒性,药物释放动力学和抗菌疗效.
主要方法:
- 使用Shirasu多孔玻璃 (SPG) 膜乳化和UV启动的聚合,合成单分散的PNIPAAm空心纳米囊.
- 封装万科米辛 (VA) 进入PNIPAAm纳米囊,形成一种水溶性PNIPAAm-VA药物输送系统.
- 在体外细胞毒性测定与人类骨髓介质干细胞和药物释放研究在不同的温度 (37°C和40°C).
主要成果:
- PNIPAAm和PNIPAAm-VA纳米囊对人类骨髓中介细胞干细胞没有表现出细胞毒性.
- PNIPAAm-VA在试验室中显示了持续释放的万科米辛 (VA),超过50%和80%在10天内分别在37°C和40°C释放.
- 释放的万科米辛有效地抑制了耐美西林黄金葡萄球菌 (MRSA) 的生长.
结论:
- 合成的PNIPAAm-VA纳米囊代表了一种安全有效的纳米尺度药物输送系统.
- 由于PNIPAAm对温度的敏感性,可以在体内进行局部控制的药物释放.
- 这种创新的注射药物具有作为局部治疗细菌感染的治疗剂的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


